Meet-the-Professor Session:
153. Virulence Mechanisms as Antimicrobial Targets: Opportunities and Challenges
Saturday, October 5, 2013: 7:00 AM-8:15 AM
Room: The Moscone Center: 250-262

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • discuss bacterial virulence as an alternative target for next generation antimicrobials
  • identify mechanisms of microbial pathogenesis that may be amenable to the development of antivirulence compounds
  • discuss the opportunities and challenges of designing appropriate clinical trials to evaluate future antivirulence drugs

Target Audience: scientists, researchers, microbiologists, lab personnel, investigators, infectious diseases physicians, hospital epidemiologists, clinicians, academicians

Tracks: Investigative ID, Epidemiology and Infection Control, Adult ID

Meet-the-professors:  Steve Projan, PhD, MedImmune, LLC and John Powers, MD, FIDSA, George Washington University School of Medicine


7:00 AM
Steve Projan, PhD

7:35 AM
John Powers, MD, FIDSA

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 CreditTM

ACPE Credits: ACPE 1.25 knowledge-based contact hours (0.125 CEU) of pharmacy CE

ACPE Number: 0221-9999-13-118-L01-P


S. Projan, MedImmune, LLC: Employee, Salary

J. Powers, None

Findings in the abstracts are embargoed until 12:01 a.m. PST, Oct. 2nd with the exception of research findings presented at the IDWeek press conferences.